Filing Details

Accession Number:
0001209191-19-028670
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-10 06:17:33
Reporting Period:
2019-05-09
Accepted Time:
2019-05-10 06:17:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
944809 Opko Health Inc. OPK Pharmaceutical Preparations (2834) 752402409
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1188834 D Ph Jane Hsiao Opko Health, Inc.
4400 Biscayne Blvd.
Miami FL 33137
Vice Chairman & Cto Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-09 6,717 $2.03 24,471,864 No 4 P Direct
Common Stock Acquisiton 2019-05-09 500 $2.04 24,472,364 No 4 P Direct
Common Stock Acquisiton 2019-05-09 2,783 $2.04 24,475,147 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,727,404 Indirect See Footnote
Common Stock 20,091,062 Indirect See Footnote
Footnotes
  1. The securities are owned directly by Hsu Gamma Investment, L.P. Dr. Hsiao is the general partner of Hsu Gamma Investment, L.P. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
  2. These securities are owned directly by The Frost Group, LLC. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.